China SXT Pharmaceuticals, Inc. (SXTC)

USD 2.51

(-5.64%)

Operating Expenses Summary of China SXT Pharmaceuticals, Inc.

  • China SXT Pharmaceuticals, Inc.'s latest annual operating expenses in 2024 was 3.06 Million USD , down -49.13% from previous year.
  • China SXT Pharmaceuticals, Inc.'s latest quarterly operating expenses in 2024 FY was 2.64 Million USD , down -56.14% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported a annual operating expenses of 6.03 Million USD in annual operating expenses 2023, down -6.33% from previous year.
  • China SXT Pharmaceuticals, Inc. reported a annual operating expenses of 6.44 Million USD in annual operating expenses 2022, up 27.89% from previous year.
  • China SXT Pharmaceuticals, Inc. reported a quarterly operating expenses of 4.82 Million USD for 2024 Q1, up 0.63% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported a quarterly operating expenses of -3.28 Million USD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Historical Annual Operating Expenses of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Year Operating Expenses Operating Expenses Growth
2024 3.06 Million USD -49.13%
2023 6.03 Million USD -6.33%
2022 6.44 Million USD 27.89%
2021 5.03 Million USD 24.52%
2020 4.04 Million USD 42.32%
2019 2.84 Million USD 60.64%
2018 1.76 Million USD 149.25%
2017 709.81 Thousand USD 21.37%
2016 584.84 Thousand USD 0.0%

Peer Operating Expenses Comparison of China SXT Pharmaceuticals, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD 62.811%
Alpha Teknova, Inc. 45.85 Million USD 93.307%
ANI Pharmaceuticals, Inc. 195.98 Million USD 98.434%
Aquestive Therapeutics, Inc. 44.85 Million USD 93.157%
Collegium Pharmaceutical, Inc. 159.2 Million USD 98.072%
Cosmos Health Inc. 26.18 Million USD 88.277%
Journey Medical Corporation 54.59 Million USD 94.378%
Embecta Corp. 528.4 Million USD 99.419%
Esperion Therapeutics, Inc. 271.89 Million USD 98.871%
Dynavax Technologies Corporation 219.14 Million USD 98.599%
Intra-Cellular Therapies, Inc. 590 Million USD 99.48%
Pacira BioSciences, Inc. 326.37 Million USD 99.06%
PainReform Ltd. 9.58 Million USD 67.976%
Sunshine Biopharma, Inc. 13.12 Million USD 76.615%
Sunshine Biopharma, Inc. 13.12 Million USD 76.615%
SCYNEXIS, Inc. 51.84 Million USD 94.08%
Safety Shot Inc 12.1 Million USD 74.655%
Procaps Group, S.A. 199.47 Million USD 98.461%
Theratechnologies Inc. 72.75 Million USD 95.782%
Harrow Health, Inc. 89.97 Million USD 96.589%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD 67.508%
Biofrontera Inc. 39.95 Million USD 92.319%
DURECT Corporation 43.71 Million USD 92.979%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 99.42%
Cronos Group Inc. 96.7 Million USD 96.826%
OptiNose, Inc. 85.1 Million USD 96.394%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 98.678%
Kala Pharmaceuticals, Inc. 39.15 Million USD 92.161%
RedHill Biopharma Ltd. -9.56 Million USD 132.101%
Organogenesis Holdings Inc. 314.13 Million USD 99.023%
Guardion Health Sciences, Inc. 9.73 Million USD 68.459%
Cumberland Pharmaceuticals Inc. 43.04 Million USD 92.869%
Radius Health, Inc. 265.92 Million USD 98.846%
Universe Pharmaceuticals INC 13.84 Million USD 77.827%
ProPhase Labs, Inc. 37.85 Million USD 91.892%
Phibro Animal Health Corporation 260.29 Million USD 98.821%
Procaps Group S.A. 187.24 Million USD 98.361%
Alvotech 285.43 Million USD 98.925%
TherapeuticsMD, Inc. 9.82 Million USD 68.761%
Viatris Inc. 5.96 Billion USD 99.949%
Rockwell Medical, Inc. 15.37 Million USD 80.037%
Aytu BioPharma, Inc. 59.84 Million USD 94.871%
SIGA Technologies, Inc. 22.04 Million USD 86.076%
Tilray Brands, Inc. 251.35 Million USD 98.779%
Lifecore Biomedical, Inc. 49.03 Million USD 93.741%
Shineco, Inc. 17.94 Million USD 82.9%
PetIQ, Inc. 192.72 Million USD 98.407%
Regencell Bioscience Holdings Limited 3.99 Million USD 23.1%
Incannex Healthcare Limited 30.05 Million USD 89.787%
Neurocrine Biosciences, Inc. 1.59 Billion USD 99.808%
Alimera Sciences, Inc. 62.64 Million USD 95.1%
Silver Spike Investment Corp. 762.49 Thousand USD -302.521%
Assertio Holdings, Inc. 368.58 Million USD 99.167%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD 47.852%
Petros Pharmaceuticals, Inc. 17.8 Million USD 82.766%
Clever Leaves Holdings Inc. 21.16 Million USD 85.501%
Cyclo Therapeutics, Inc. 21.04 Million USD 85.414%
Avadel Pharmaceuticals plc 164.96 Million USD 98.14%
Hempacco Co., Inc. 7.59 Million USD 59.597%
Talphera, Inc. 11.99 Million USD 74.411%
Alvotech 285.43 Million USD 98.925%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 97.819%
Lantheus Holdings, Inc. 344.9 Million USD 99.11%
Currenc Group, Inc. 24 Million USD 87.213%
Kamada Ltd. 45.42 Million USD 93.244%
Indivior PLC 911 Million USD 99.663%
Evoke Pharma, Inc. 12.4 Million USD 75.268%
Flora Growth Corp. 10.57 Million USD 70.988%
Cyclo Therapeutics, Inc. 21.04 Million USD 85.414%
Evolus, Inc. 189.75 Million USD 98.383%
HUTCHMED (China) Limited 436.23 Million USD 99.296%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 98.009%
Akanda Corp. 3.48 Million USD 11.894%